Dr. Mahendra Takashi Bhati, MD

Dr. Bhati practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Bhati's NPI, 1013052513, was assigned on February 21, 2007. Dr. Bhati graduated from LSU Health Shreveport School of Medicine in 2001. Dr. Bhati holds California license C141001.

Dr. Bhati's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Bhati's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Bhati to 1 more hospital and 1 group practice or clinic, each named with a free account. Dr. Bhati's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhati practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Bhati's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Bhati is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Bhati's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists anxiety, bipolar disorder and depression among the conditions Dr. Bhati treats.

CMS data shows 294 Medicare services from Dr. Bhati across 4 procedure codes in 2024, for 77 Medicare patients. Medicare paid $34,828 for them.

CMS counts 77 Medicare patients who saw Dr. Bhati in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have depression, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bhati's median patient age at 44, with 54% women.

In 2024, Dr. Bhati wrote 98 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 65 of them, across 4 drugs with 11 or more claims each, at $2,376 in total drug cost. In 2023, CMS named 52 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Bhati for performance year 2024, reported as part of a group. Dr. Bhati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhati as offering telehealth.

Dmand AI links 27 papers to Dr. Bhati, published from 2007 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Deep Brain Stimulation, Depressive Disorder, Treatment-Resistant and Depression. Dr. Bhati has published most often in J Neurol Neurosurg Psychiatry. Dr. Bhati's most frequent co-authors are Irving Michael Reti, MD, Jesse H. Wright, MD and Gordon H. Baltuch, MD.

Dmand AI links Dr. Bhati to 5 clinical trials. Conditions studied include Depressive Disorder, Major, Depressive Disorder and Depressive Disorder, Treatment-Resistant.

CMS Open Payments shows 13 general payments to Dr. Bhati from 3 drug and device companies from 2017 to 2024. Travel and lodging make up the largest share, 57% of the total. Abbott Laboratories paid the most, $1,326.

Dmand AI lists 20 awards for Dr. Bhati, most recently Health Care Hero in 2014.

Dr. Bhati graduated from LSU Health Shreveport School of Medicine in 2001. Dr. Bhati is a member of AMA and APA.

Dr. Bhati is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.